Publication | Closed Access

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

Metastatic Breast CancerOncologyBreast OncologyVersus CyclophosphamidePhase IiiPharmacologyClinical TrialsBreast CancerPharmacotherapyCancer TreatmentMedicine